Biomarin Pharmaceutical Q3 2026 Earnings Call Transcript - BioMarin Pharmaceutical

By America Pulse · Based on reporting from benzinga.com

BioMarin Pharmaceutical Reaches Billion Dollar Revenue Milestone in Q3 2026

BioMarin Pharmaceutical, Inc. reached a historic financial landmark during the third quarter of 2026, as the company reported its first-ever three-month period with revenues exceeding the $1 billion mark. This achievement, disclosed during the firm's recent earnings call, highlights a period of rapid expansion for the California-based biotechnology company. According to the financial data released by the organization, the total revenue for the quarter represents a 32% increase when compared to the same timeframe in the previous year. This significant jump in fiscal performance suggests that the company is successfully executing its commercial strategy on a global scale.

Revenue Growth Surpasses ONE Billion

The jump

Source: benzinga.com · 2026-11-02